These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
190 related items for PubMed ID: 9039200
1. One-week therapy with twice-daily butenafine 1% cream versus vehicle in the treatment of tinea pedis: a multicenter, double-blind trial. Savin R, De Villez RL, Elewski B, Hong S, Jones T, Lowe N, Lucky A, Reyes B, Stewart D, Willis I. J Am Acad Dermatol; 1997 Feb; 36(2 Pt 1):S15-9. PubMed ID: 9039200 [Abstract] [Full Text] [Related]
2. Treatment of interdigital tinea pedis with a 4-week once-daily regimen of butenafine hydrochloride 1% cream. Tschen E, Elewski B, Gorsulowsky DC, Pariser DM. J Am Acad Dermatol; 1997 Feb; 36(2 Pt 1):S9-14. PubMed ID: 9039199 [Abstract] [Full Text] [Related]
3. Butenafine 1% cream in the treatment of tinea cruris: a multicenter, vehicle-controlled, double-blind trial. Lesher JL, Babel DE, Stewart DM, Jones TM, Kaminester L, Goldman M, Weintraub JS. J Am Acad Dermatol; 1997 Feb; 36(2 Pt 1):S20-4. PubMed ID: 9039201 [Abstract] [Full Text] [Related]
4. Butenafine, a fungicidal benzylamine derivative, used once daily for the treatment of interdigital tinea pedis. Reyes BA, Beutner KR, Cullen SI, Rosen T, Shupack JL, Weinstein MB. Int J Dermatol; 1998 Jun; 37(6):450-3. PubMed ID: 9646136 [No Abstract] [Full Text] [Related]
5. A randomized trial to assess once-daily topical treatment of tinea corporis with butenafine, a new antifungal agent. Greer DL, Weiss J, Rodriguez DA, Hebert AA, Swinehart JM. J Am Acad Dermatol; 1997 Aug; 37(2 Pt 1):231-5. PubMed ID: 9270509 [Abstract] [Full Text] [Related]
6. Efficacy and safety of naftifine HCl Gel 2% in the treatment of interdigital and moccasin type tinea pedis: pooled results from two multicenter, randomized, double-blind, vehicle-controlled trials. Stein Gold LF, Parish LC, Vlahovic T, Plaum S, Kircik L, Fleischer AB, Verma A, Olayinka B, Hardas B. J Drugs Dermatol; 2013 Aug; 12(8):911-8. PubMed ID: 23986165 [Abstract] [Full Text] [Related]
7. Naftifine Hydrochloride Gel 2%: An Effective Topical Treatment for Moccasin-Type Tinea Pedis. Stein Gold LF, Vlahovic T, Verma A, Olayinka B, Fleischer AB. J Drugs Dermatol; 2015 Oct; 14(10):1138-44. PubMed ID: 26461826 [Abstract] [Full Text] [Related]
8. Topical butenafine for tinea pedis. Med Lett Drugs Ther; 1997 Jul 04; 39(1004):63-4. PubMed ID: 9217695 [No Abstract] [Full Text] [Related]
9. Efficacy of a 1-week, twice-daily regimen of terbinafine 1% cream in the treatment of interdigital tinea pedis. Results of placebo-controlled, double-blind, multicenter trials. Berman B, Ellis C, Leyden J, Lowe N, Savin R, Shupack J, Stiller M, Tschen E, Zaias N, Birnbaum JE. J Am Acad Dermatol; 1992 Jun 04; 26(6):956-60. PubMed ID: 1607415 [Abstract] [Full Text] [Related]
10. Econazole nitrate foam 1% for the treatment of tinea pedis: results from two double-blind, vehicle-controlled, phase 3 clinical trials. Elewski BE, Vlahovic TC. J Drugs Dermatol; 2014 Jul 04; 13(7):803-8. PubMed ID: 25007362 [Abstract] [Full Text] [Related]
11. Butenafine hydrochloride: for the treatment of interdigital tinea pedis. Syed TA, Maibach HI. Expert Opin Pharmacother; 2000 Mar 04; 1(3):467-73. PubMed ID: 11249531 [Abstract] [Full Text] [Related]
12. Comparative efficacy of topical 1% butenafine and 1% clotrimazole in tinea cruris and tinea corporis: a randomized, double-blind trial. Singal A, Pandhi D, Agrawal S, Das S. J Dermatolog Treat; 2005 Mar 04; 16(5-6):331-5. PubMed ID: 16428155 [Abstract] [Full Text] [Related]
13. Ciclopirox gel in the treatment of patients with interdigital tinea pedis. Aly R, Fisher G, Katz I, Levine N, Lookingbill DP, Lowe N, Menter A, Morman M, Pariser DM, Roth HL, Savin RC, Shavin JS, Stewart D, Taylor JR, Tucker S, Wortzman M. Int J Dermatol; 2003 Sep 04; 42 Suppl 1():29-35. PubMed ID: 14567368 [Abstract] [Full Text] [Related]
14. Efficacy and safety of a new single-dose terbinafine 1% formulation in patients with tinea pedis (athlete's foot): a randomized, double-blind, placebo-controlled study. Ortonne JP, Korting HC, Viguié-Vallanet C, Larnier C, Savaluny E. J Eur Acad Dermatol Venereol; 2006 Nov 04; 20(10):1307-13. PubMed ID: 17062050 [Abstract] [Full Text] [Related]
15. Comparable efficacy and safety of various topical formulations of terbinafine in tinea pedis irrespective of the treatment regimen: results of a meta-analysis. Korting HC, Kiencke P, Nelles S, Rychlik R. Am J Clin Dermatol; 2007 Nov 04; 8(6):357-64. PubMed ID: 18039018 [Abstract] [Full Text] [Related]
16. Efficacy and safety of terbinafine 1% solution in the treatment of interdigital tinea pedis and tinea corporis or tinea cruris. Lebwohl M, Elewski B, Eisen D, Savin RC. Cutis; 2001 Mar 04; 67(3):261-6. PubMed ID: 11270304 [Abstract] [Full Text] [Related]
17. Efinaconazole Topical Solution, 10% Efficacy in Patients with Onychomycosis and Coexisting Tinea Pedis. Markinson B, Caldwell B. J Am Podiatr Med Assoc; 2015 Sep 04; 105(5):407-11. PubMed ID: 26429609 [Abstract] [Full Text] [Related]
18. Comparison of one week of oral terbinafine (250 mg/day) with four weeks of treatment with clotrimazole 1% cream in interdigital tinea pedis. Barnetson RS, Marley J, Bullen M, Brookman S, Cowen P, Ellis D, Williams T. Br J Dermatol; 1998 Oct 04; 139(4):675-8. PubMed ID: 9892913 [Abstract] [Full Text] [Related]
19. Efficacy and tolerability of terbinafine 1% topical solution used for 1 week compared with 4 weeks clotrimazole 1% topical solution in the treatment of interdigital tinea pedis: a randomized, double-blind, multi-centre, 8-week clinical trial. Schopf R, Hettler O, Bräutigam M, Weidinger G, Kaben U, Mayser P, Resl V. Mycoses; 1999 Oct 04; 42(5-6):415-20. PubMed ID: 10536434 [Abstract] [Full Text] [Related]
20. The safety and efficacy of sertaconazole nitrate cream 2% for tinea pedis. Savin R, Jorizzo J. Cutis; 2006 Oct 04; 78(4):268-74. PubMed ID: 17121064 [Abstract] [Full Text] [Related] Page: [Next] [New Search]